SCHEMBL19081828

SCHEMBL19081828

c1ccc(-c2ccc(-c3c4ccccc4c(-c4c5oc6ccc7ccccc7c6c5cc5sc6ccccc6c45)c4ccccc34)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 6/20 0.39
CYP1A1 P04798 3/20 0.39
CYP1A2 P05177 3/20 0.39
PAX8 Q06710 2/20 0.39
AHR P35869 2/20 0.39
FYN P06241 1/20 0.39
MAPK3 P27361 1/20 0.39
NPC1 O15118 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
NQO1 P15559 1/20 0.34
NQO2 P16083 1/20 0.34
RAB9A P51151 1/20 0.34
PTPN1 P18031 2/20 0.32
CYP1B1 Q16678 2/20 0.32
MAPK1 P28482 2/20 0.32
KDM4E B2RXH2 1/20 0.32
PDE5A O76074 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
ABCB1 P08183 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082025 0.92 ABCG2 (0.38) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL19081919 0.91 ABCG2 (0.39) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL19081844 0.89 ABCG2 (0.34) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL19081830 0.84 ABCG2 (0.39) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL19081772 0.84 ESR2 (0.36) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL19081951 0.84 AHR (0.34) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL19081904 0.83 ABCG2 (0.40) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL19081773 0.83 ABCG2 (0.40) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL31010715 0.81 ABCG2 (0.49) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL22680414 0.81 ABCG2 (0.49) ABCG2CYP1A1CYP1A2PAX8AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885CYP1A1 184/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885CYP1A1 184/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.